Back to MORGAN STANLEY MORGAN STANLEY

DSGNDSGN
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in DESIGN THERAPEUTICS INC

MORGAN STANLEY holds 765,425 shares of DSGN (DESIGN THERAPEUTICS INC), worth $11.1M as of 2026-Q2. The position was increased (+16.6% shares). DSGN represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$11.1M

Current Shares

765,425

Total Value Change

+$9.8M

Total Shares Change

+375,988

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
765,425
+16.6%
$11.1M0.0%$14.47
32
2026-Q1
Decreased
656,565
-6.5%
$7M0.0%$10.00
0
2025-Q4
Increased
702,306
+299.1%
$6.6M0.0%$9.79
44
2025-Q3
Decreased
175,991
-17.6%
$1.3M0.0%$6.85
0
2025-Q2
Decreased
213,550
-13.8%
$719,6630.0%$3.57
0
2025-Q1
Decreased
247,878
-28.4%
$956,8080.0%$4.21
0
2024-Q4
Decreased
346,183
-19.3%
$2.1M0.0%$6.17
0
2024-Q3
Increased
428,798
+10.1%
$2.3M0.0%$5.33
29
2024-Q2
New
389,437
-
$1.3M0.0%$3.35
35

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used